The evidence suggests that insulin stimulates tumor growth by decreasing the production of insulin-like growth factor-binding protein 1 (IGFBP-1) [33], increasing the tissue bioavailability of Insuline-like growth factor (IGF)-I, or inhibiting apoptosis [34]. This evidence concerns the gene IGFBPL1 and neoplasm.